![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H23NO2 |
Molar mass | 345.442 g·mol−1 |
3D model (JSmol) | |
| |
|
Crisnatol (BW-A770U) is an experimental anticancer agent.[1] A Phase I clinical trial was published in 1999.[2]